The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition.

Name: The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition.
Author: Spanoudakis, Emmanouil

The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition. — المؤلف: Spanoudakis, Emmanouil — Mediterranean journal of hematology and infectious diseases 2018

المؤلف: Spanoudakis, Emmanouil
النشر: Mediterranean journal of hematology and infectious diseases 2018
الوصف: e2018058 p.